0001493152-19-003665.txt : 20190320 0001493152-19-003665.hdr.sgml : 20190320 20190320172407 ACCESSION NUMBER: 0001493152-19-003665 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190320 DATE AS OF CHANGE: 20190320 EFFECTIVENESS DATE: 20190320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC CENTRAL INDEX KEY: 0000830656 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 042652826 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-335342 FILM NUMBER: 19695336 BUSINESS ADDRESS: STREET 1: 14 NORFOLK AVENUE CITY: SOUTH EASTON STATE: MA ZIP: 02375 BUSINESS PHONE: 5082301828 MAIL ADDRESS: STREET 1: 14 NORFOLK AVENUE CITY: SOUTH EASTON STATE: MA ZIP: 02375 FORMER COMPANY: FORMER CONFORMED NAME: BOSTON BIOMEDICA INC DATE OF NAME CHANGE: 19960812 D 1 primary_doc.xml X0708 D LIVE 0000830656 PRESSURE BIOSCIENCES INC 14 NORFOLK AVENUE SOUTH EASTON MA MASSACHUSETTS 02375 (508)230-1828 MASSACHUSETTS None BOSTON BIOMEDICA INC Corporation true Richard T. Schumacher 14 Norfolk Avenue South Easton MA MASSACHUSETTS 02375 Executive Officer Director President, Chief Executive Officer, Treasurer and Clerk Richard P. Thomley 14 Norfolk Avenue South Easton MA MASSACHUSETTS 02375 Executive Officer Acting Chief Financial Officer Kevin A. Pollack 14 Norfolk Avenue South Easton MA MASSACHUSETTS 02375 Director Vito J. Mangiardi 14 Norfolk Avenue South Easton MA MASSACHUSETTS 02375 Director Michael S. Urdea 14 Norfolk Avenue South Easton MA MASSACHUSETTS 02375 Director Chairman of the Board Jeffrey N. Peterson 14 Norfolk Avenue South Easton MA MASSACHUSETTS 02375 Director Chairman of the Board Biotechnology $1,000,001 - $5,000,000 06b false 2018-05-02 true true true true false 0 None None Garden State Securities, Inc. 10083 328 NEWMAN SPRINGS ROAD RED BANK NJ NEW JERSEY 07701 All States false Indefinite 17459551 Indefinite From May 2, 2018 through March 6, 2019, the Company sold the securities detailed in Item 9 for a total purchase price of $4,288,000. During the same period, the company converted debt equal to $13,171,551 into the securities detailed in Item 9. false 43 416300 0 Warrants for 318,680 shares with an exercise price of $3.50 per share were issued to Garden State as compensation in addition to their sales commissions. 0 true false PRESSURE BIOSCIENCES INC /s/ Richard T. Schumacher Richard T. Schumacher President, CEO, Treasurer, Clerk and Director 2019-03-20